Skip to content

Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation

Pulmonary Embolism Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04980924
Acronym
REMATEV
Enrollment
547
Registered
2021-07-28
Start date
1992-01-01
Completion date
1997-12-31
Last updated
2025-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Brief summary

This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.

Interventions

OTHERno intervention

no intervention

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* All pulmonary embolisms hospitalised in Nice hospital. * acceptation to enter in the cohorte survey

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Reccurence10 yearsnumber of patient with Documented symptomatic pulmonary embolism reccurence

Secondary

MeasureTime frameDescription
Pulmonary hypertension10 yearsnumber of patients with Confirmed pulmonary hypertension after pulmonary embolism
Chronic pulmonary disease without hypertension10 yearsnumber of patients with dyspnea but without pulmonary hypertension, Documented non-reperfused pulmonary areas

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026